FDA approves cardiac output monitoring device
One of the medical device company Retia medical announced new device called Argos cardiac output monitor. It has been received US FDA clearance and is now available for sales in the US.
Argos cardiac output monitor can dramatically improve proactive clinical decision-making for high risk surgical and critically ill patients and improves operating room and intensive care unit.
Argos cardiac output monitor is a hemodynamic monitor that tracks oxygen delivery and allows clinicians to maintain optimal fluid status. The new device interface with new existing clinical monitors and electronic medical record systems and eliminating disposable costs.
The features of the Argos cardiac output monitor is:
- Highly accurate
- The device is easy to use
- Cost effective
- Simple EMR connectivity